A survey of the management of newborns with severe hemophilia in Canada.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3805619)

Published in Paediatr Child Health on April 01, 2013

Authors

Paul C Moorehead1, Jamie Ray2, Nicholas J Barrowman3, Brigitte Lemyre4, Robert Klaassen4

Author Affiliations

1: Division of Pediatric Hematology/Oncology, Janeway Child Health and Rehabilitation Centre, St John's, Newfoundland and Labrador, Ottawa, Ontario.
2: University of Ottawa, Ottawa, Ontario.
3: Department of Pediatrics, University of Ottawa, Ottawa, Ontario ; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario.
4: Department of Pediatrics, University of Ottawa, Ottawa, Ontario.

Articles cited by this

Guidelines for the management of hemophilia. Haemophilia (2012) 5.16

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost (2004) 2.20

Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics (2003) 1.71

The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery. Haemophilia (2009) 1.24

The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery. Haemophilia (2009) 1.23

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006). Haemophilia (2009) 1.19

Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group. Thromb Haemost (1992) 1.06

Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia (2005) 0.99

Intracranial hemorrhage in newborn and young infants with hemophilia. J Pediatr (1988) 0.97

Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood (1997) 0.97

Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia (2009) 0.93

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B. Haemophilia (2011) 0.89

Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia (1999) 0.88

Guideline on the management of haemophilia in the fetus and neonate. Br J Haematol (2011) 0.87

Effect of intracranial bleeds on the neurocognitive, academic, behavioural and adaptive functioning of boys with haemophilia. Haemophilia (2011) 0.82

Haemophilia A in two premature infants. Eur J Pediatr (2004) 0.80

Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia (1998) 0.79

A case report of a premature infant with haemophilia A and factor VIII inhibitor. Haemophilia (2011) 0.78

Management of neonates with inherited bleeding disorders--a survey of current UK practice. Haemophilia (2005) 0.78

Severe haemophilia and extreme prematurity--a case report. Haemophilia (2008) 0.78

Management of haemophilia in three premature infants. Haemophilia (2007) 0.78